Reaching 90% HIV Suppression: The Role of POC Viral Load Monitoring in Nigeria

NACompletedINTERVENTIONAL
Enrollment

543

Participants

Timeline

Start Date

April 9, 2018

Primary Completion Date

February 28, 2021

Study Completion Date

February 28, 2021

Conditions
HIV/AIDS
Interventions
DIAGNOSTIC_TEST

Point-of-care viral load monitoring test

For enumerating viral load for patients in the POC arm, we will use the Cepheid Xpert® HIV-1 Viral Load test, a quantitative assay with a quantification range of 40 to 10,000,000 copies/mL. Based on the GeneXpert® technology, Xpert HIV-1 VL automates the test process, including RNA extraction, purification, reverse transcription and cDNA real-time quantitation in one fully integrated cartridge. The pre-loaded disposable single-use cartridges provide a visual read-out within 90 minutes. The assay requires 1 mL of plasma using a precision pipette (1.2 mL using a transfer pipette).

Trial Locations (2)

Unknown

Jos University Teaching Hospital, Jos

Comprehensive Health Care Centre, Zamko, Zamko

All Listed Sponsors
collaborator

Jos University Teaching Hospital

OTHER

collaborator

Centers for Disease Control and Prevention

FED

lead

Harvard School of Public Health (HSPH)

OTHER

NCT03533868 - Reaching 90% HIV Suppression: The Role of POC Viral Load Monitoring in Nigeria | Biotech Hunter | Biotech Hunter